Answer
FEIBA can cause severe, systemic allergic reactions, including anaphylaxis with circulatory shock; administration should be stopped and appropriate medical care initiated at the first sign or symptom of an infusion or hypersensitivity reaction.
Sources for this answer
- FEIBA 100 U/ml powder and solvent for solution for infusionTakeda UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked